Perspectives of stem cell therapies for retinal conditions
Retina Australia has partnered with researchers at the University of New South Wales to...
AAV-Based Gene Therapy for Retinal Diseases: A 2025 update
Retina Australia 2025 grant awardee, Dr Jiang-Hui (Sloan) Wang, PhD (Research Fellow), from the...
Vision improvements from Australia’s “second generation” bionic eye
Image is courtesy of Anna Carlile Summary Advancements in retinal prosthesis...
Podcast: The Australian Bionic Eye Project
Talking Eyes with Lien Trinh Guest speaker: Associate Professor Penelope Allen Talking Eyes is an Australian podcast dedicated to exploring the...
5 Years of Luxturna
5 years of Luxturna - The first gene therapy for an IRD ERN-EYE hosted a webinar in late January 2025 to mark five years since the first gene therapy for...
Podcast: Fixing the Code for Inherited Retinal Diseases
Talking Eyes with Lien Trinh Guest speaker: Dr Tom Edwards In this Talking Retina episode, Fixing...
First treatment for geographic atrophy approved in Australia
Apellis' SYFOVRE® (pegcetacoplan) TGA Approved Apellis Pharmaceuticals, Inc. announced today that Australia’s Therapeutic Goods Administration...
Podcast: Dealing with inherited retinal disease
Talking Eyes with Lien Trinh Guest speaker: Professor Lauren Ayton Talking Eyes is an Australian podcast dedicated to exploring the latest...
World Research Summary by Dr Catherine Civil
Hot Off The Press Welcome back to you all and I hope you all had a delightful festive season. I have...
Professor Jean Bennett – Melbourne November 2024
It was great for Rosemary and I to meet up with Professor Jean Bennett...
New Research: Forty-year odyssey to Refsum disease diagnosis: impact of diagnostic delay on effective treatment
Often misdiagnosed as retinitis pigmentosa (RP), with the average...
World Geographic Atrophy Day 2024
For World Geographic Atrophy Day 2024 on 5th December, Retina Australia is raising awareness for this leading cause of vision loss in people over...
Are there IRD treatments available?
One IRD treatment in Australia In Australia, there is currently one regulatory-approved therapy for an IRD, a gene therapy called Luxturna® (voretigene neparvovec-rzyl, Novartis), for...
IRD Diagnosis and genetic testing
How do I know what type of IRD I have? Difficulty in diagnosis When first diagnosed with an IRD, the disease name can vary between doctors...
In Focus: Inherited retinal disease
What is an inherited retinal disease? An inherited retinal disease (IRD) is a condition caused by a genetic anomaly that leads to loss of vision...
Cell therapy, genetic research and a patient’s perspective
This is a summary of the webinar that was presented on Saturday 19th October...
New Research: Comparison of Long Cane and Electronic Travel Aids for Mobility
The research study, "Functional performance comparison of long cane...
World Research Summary by Dr Catherine Civil
Hot Off The Press More updates on the latest research: CRISPR-Cas13 and RNA We have just about got our heads around the...
World Research Summary by Dr Catherine Civil
Hot Off The Press More updates on the latest research: Gene therapy is improving vision in Bothnia Dystrophy Bothnia dystrophy is a...
World Sight Day 2024
Love Your Child's Eyes Retina Australia is joining Vision 2020 Australia and the International Agency for the Prevention of Blindness (IAPB) again this year in raising awareness for eye health...